Stockreport

Alamar Biosciences: Looking For An Early Detection [Seeking Alpha]

Alamar Biosciences, Inc. - Class A common stock  (ALMR) 
PDF Alamar's revenue nearly tripled to $74M in 2025, with annualized sales multiples now around 12x; losses narrowed but remain substantial. Strong cash reserves and rapi [Read more]